Press release of Corporate Actions Committee- Athens Stock Exchange (ATHEX)
|
|
![]() |
November 14, 2017
Corporate Actions Committee - Athens Stock Exchange (ΑΤΗΕΧ)
The Athens Stock Exchange, following today's session of its Corporate Actions Committee, announces that on Thursday, November 16th, 2017 the 163,984,878 new common registered shares of "FRIGOGLASS S.A." (ISIN:GRS346003007), which resulted from the share capital increase realized due to the conversion of 163,984,878 bonds, will commence trading on ATHEX.
| Download the Press Release |
![]() |
About Athens Exchange Group
The Athens Stock Exchange since its establishment in 1876, consistently participate in the financial and business developments in the country.
Athens Exchange Group (ATHEX Group), provides support to the Greek Capital Market. ATHEX Group operates the organized Equities and Derivatves markets, the alternative market and performs clearing and settlement of trades.
The Athens Stock Exchange, through its markets, offers solutions and financing tools to businesses, expands investor choice by providing a safe, stable and easy environment in full alignment with international practices and the European regulatory framework. It has held the ISO 22301:2012 international standard for Business Continuity, for all its companies, including all its operations as well as the products & services it provides.
In a period that the role of stock markets in exploring alternative ways of financing business, at a European level, is significantly enhanced, the Athens Exchange Group has taken a series of initiatives to highlight the attractiveness of the Greek Capital Market and the Greek companies to the international investment community and expand the variety of investment opportunities.
Its shares are traded on the Main Market of the Athens Stock Exchange (Symbol: EXAE).
The profiles of the ATHEX Group and its markets can be downloaded from the link. More information can be found in the website www.athexgroup.gr.
110 Athinon Ave. 10442 Athens, Greece, tel +30-210 3366 800, fax +30 210-3366 101


